[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cocaine-use-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":125,"states":126},"Cocaine Use Disorder",18,14,[8,15,22,28,35,41,47,53,59,66,72,78,84,90,96,103,110,118],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT07490600","Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder",[],"RECRUITING","2026-08-26T02:16:41.943926Z","2026-07-05T03:45:20.252584Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07624227","The Impact of Cobenfy Maintenance on Cocaine's Effects",[19],"Phase 1\u002FPhase 2","2026-08-26T02:15:25.633039Z","2026-06-04T01:30:07.906556Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT05974202","rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder",[],"2026-08-26T02:18:51.009190Z","2026-05-05T02:43:29.682307Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT06691243","Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV",[32],"Phase 2","2026-08-26T02:19:27.519777Z","2026-05-05T02:43:29.156738Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT07227948","Repurposing Semaglutide for the Treatment of Cocaine Use Disorder",[32],"2026-08-26T02:17:36.611194Z","2026-05-05T02:43:28.173928Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT07318480","Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder",[],"2026-08-26T02:18:20.384845Z","2026-05-05T02:43:27.856428Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT05886582","Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder",[32],"2026-08-26T02:15:40.343619Z","2026-05-05T02:43:26.977900Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":57,"content_modified":58},"NCT04721418","Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study",[],"2026-08-03T02:36:50.517616Z","2026-05-13T02:55:06.266957Z",{"nct_id":60,"title":61,"phases":62,"status":12,"updated_at":64,"content_modified":65},"NCT05011760","[C-11]NPA PET-amphetamine in Cocaine Use Disorders",[63],"Early Phase 1","2026-08-26T02:17:22.153941Z","2026-05-05T02:43:29.369857Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":70,"content_modified":71},"NCT07091877","Cocaine Cue-reactivity Incubation Study",[],"2026-08-26T02:18:17.950264Z","2026-05-05T02:43:28.311984Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":76,"content_modified":77},"NCT07086794","Cocaine and Pentoxifylline (BED IN 47)",[63],"2026-08-26T02:18:26.932189Z","2026-05-05T02:43:27.918274Z",{"nct_id":79,"title":80,"phases":81,"status":12,"updated_at":82,"content_modified":83},"NCT05008146","Imaging CRF X NOP Interactions in CUD",[63],"2026-08-26T02:19:02.550788Z","2026-05-05T02:43:27.646576Z",{"nct_id":85,"title":86,"phases":87,"status":12,"updated_at":88,"content_modified":89},"NCT05986578","Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder",[],"2026-08-26T02:17:55.355429Z","2026-05-05T02:43:26.728064Z",{"nct_id":91,"title":92,"phases":93,"status":12,"updated_at":94,"content_modified":95},"NCT04927143","Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives",[],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:26.936484Z",{"nct_id":97,"title":98,"phases":99,"status":100,"updated_at":101,"content_modified":102},"NCT07661823","QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64\u002F074,526, 64\u002F063,557, 63\u002F903,181, 63\u002F729,428",[],"NOT_YET_RECRUITING","2026-08-26T02:18:26.129155Z","2026-07-05T03:45:20.367813Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT07221396","LDART for Stimulant Use Disorder",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:15.156099Z","2026-05-05T02:43:27.600329Z",{"nct_id":111,"title":112,"phases":113,"status":115,"updated_at":116,"content_modified":117},"NCT05766631","Treating Polysubstance Use Using a Novel Digital Technology",[114],"Phase 3","ACTIVE_NOT_RECRUITING","2026-08-03T02:42:53.338012Z","2026-05-05T02:43:28.714560Z",{"nct_id":119,"title":120,"phases":121,"status":122,"updated_at":123,"content_modified":124},"NCT06434818","Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders",[32],"UNKNOWN","2026-08-03T02:12:21.768801Z","2026-05-05T02:43:27.638306Z",[],[127,131,134],{"state":128,"count":129,"slug":130},"Maryland",3,"maryland",{"state":132,"count":129,"slug":133},"New York","new-york",{"state":135,"count":129,"slug":136},"Texas","texas"]